Literature DB >> 23666249

Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity.

Luminita H Pojoga1, Rene Baudrand, Gail K Adler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23666249      PMCID： PMC3844150          DOI： 10.1093/eurheartj/eht158

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  16 in total

Review 1.  Cell membrane-associated mineralocorticoid receptors? New evidence.

Authors:  Alexander W Krug; Luminita H Pojoga; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2011-04-11       Impact factor: 10.190

2.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

3.  Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.

Authors:  Luminita H Pojoga; Zuzana Adamová; Abhinav Kumar; Amanda K Stennett; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

4.  Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.

Authors:  Fabrice Ivanes; Sophie Susen; Frédéric Mouquet; Pascal Pigny; François Cuilleret; Karine Sautière; Jean-Philippe Collet; Farzin Beygui; Bernadette Hennache; Pierre Vladimir Ennezat; Françis Juthier; Florence Richard; Jean Dallongeville; Marieke A Hillaert; Pieter A Doevendans; Brigitte Jude; Michel Bertrand; Gilles Montalescot; Eric Van Belle
Journal:  Eur Heart J       Date:  2011-06-30       Impact factor: 29.983

Review 5.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

6.  Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

Authors:  Christine Guo; Diego Martinez-Vasquez; Gonzalo P Mendez; Maria F Toniolo; Tham M Yao; Eveline M Oestreicher; Taisuke Kikuchi; Nathalie Lapointe; Luminita Pojoga; Gordon H Williams; Vincent Ricchiuti; Gail K Adler
Journal:  Endocrinology       Date:  2006-08-10       Impact factor: 4.736

Review 7.  Human obesity and endothelium-dependent responsiveness.

Authors:  Umberto Campia; Manfredi Tesauro; Carmine Cardillo
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.

Authors:  René Baudrand; Cristian A Carvajal; Arnoldo Riquelme; Mauricio Morales; Nancy Solis; Margarita Pizarro; Alex Escalona; Camilo Boza; Gustavo Pérez; Angélica Domínguez; Marco Arrese; Carlos E Fardella
Journal:  Obes Surg       Date:  2009-08-19       Impact factor: 4.129

9.  Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.

Authors:  Amanda J Rickard; James Morgan; Greg Tesch; John W Funder; Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2009-07-27       Impact factor: 10.190

10.  Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion.

Authors:  Massimiliano Caprio; Brenna G Newfell; Andrea la Sala; Wendy Baur; Andrea Fabbri; Giuseppe Rosano; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Circ Res       Date:  2008-05-08       Impact factor: 17.367
View more
  6 in total

Review 1.  Cortisol dysregulation in obesity-related metabolic disorders.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

2.  Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.

Authors:  R Garg; L Kneen; G H Williams; G K Adler
Journal:  Diabetes Obes Metab       Date:  2013-10-31       Impact factor: 6.577

Review 3.  Cellular mechanisms underlying obesity-induced arterial stiffness.

Authors:  Annayya R Aroor; Guanghong Jia; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

4.  Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.

Authors:  Jacqueline N Minas; Max A Thorwald; Debra Conte; Jose-Pablo Vázquez-Medina; Akira Nishiyama; Rudy M Ortiz
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-11       Impact factor: 2.557

5.  Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.

Authors:  Rajesh Garg; Ajay D Rao; Maria Baimas-George; Shelley Hurwitz; Courtney Foster; Ravi V Shah; Michael Jerosch-Herold; Raymond Y Kwong; Marcelo F Di Carli; Gail K Adler
Journal:  Diabetes       Date:  2014-08-14       Impact factor: 9.461

Review 6.  The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.

Authors:  Annayya R Aroor; Vincent G Demarco; Guanghong Jia; Zhe Sun; Ravi Nistala; Gerald A Meininger; James R Sowers
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.